Philips Laura A
Philips Laura A, DIR, reported a transaction classified as grant at Niki BioSolutions, Inc. involving 8000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 8000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Jul 22, 2026
- Filing date
- Oct 21, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingNIKI price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001213900-26-111385 Stock Options
- Transaction date
- Jul 22, 2026 Filed Oct 21, 2026, 08:51 PM · 91d delay
- Shares
- 8,000 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 8,000 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - delayed_filing-6 points
reporting_delay_days = 91
Filing delay exceeds the configured threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
The options vest as follows: (i) 2,000 options vested immediately upon the closing of the merger; and (ii) the remaining 6,000 options vest in three equal quarterly installments of 2,000 options each,…
0 other transactions
0 recent txs